Otair Al,H. Al . .Pulmonary Arterial Hypertension in Saudi Patients with Systemic Sclerosis: Clinical and Hemodynamic Characteristics and Mortality. ” Annals of Thoracic Medicine, 14(2019) : 83.
Åkesson A.,Wollheim F.A. . .Organ Manifestations in 100 Patients with Progressive Systemic Sclerosis: A Comparison between the CREST Syndrome and Diffuse Scleroderma. ” Rheumatology, 28(1989) : 281-286.
Ioannidis J.P.A. .2004 .Mortality in Systemic Sclerosis: An International Meta-Analysis of Individual Patient Data. American Journal of Medicine, 04(1) : 2-10.
Al-Dhaher F.F. .2008 .Determinants of Morbidity and Mortality of Systemic Sclerosis in Canada.” Seminars in Arthritis and Rheumatism. , 06(4) : 269-277.
Hashimoto A.,April 2012 . .. Clinical Features of 405 Japanese Patients with Systemic Sclerosis.” Modern Rheumatology, 22(2) : 272-279.
Van Den Hoogen .2013 .“2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League against Rheumatism Collaborative Initiative.” Annals of the Rheumatic Diseases. , 72(11) : 1747-1755.
LeRoy E.C. . .Scleroderma (Systemic Sclerosis): Classification, Subsets and Pathogenesis. ” Journal of Rheumatology, 15(1988) : 202-205.
Rose S. . .. Gastrointestinal Manifestations of Scleroderma.” Gastroenterology Clinics of North America, 8553(05) : 70021-2.
Al-Dhaher F.F. .2008 .Determinants of Morbidity and Mortality of Systemic Sclerosis in Canada.” Seminars in Arthritis and Rheumatism. , 06(4) : 269-277.
Steen V.D.,April 2005 . .Kidney Disease Other than Renal Crisis in Patients with Diffuse Scleroderma. ” Journal of Rheumatology, 32(4) : 649-655.
Levey A.S. . .Definition and Classification of Chronic Kidney Disease: A Position Statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 67(2005) : 2089-2100.
Hatano S.T.,Strasser S.T. .1975 .. Primary Pulmonary Hypertension: Report on a WHO Meeting, : .
Schachna L. .2098 .. Age and Risk of Pulmonary Arterial Hypertension in Scleroderma.” Chest, 10(6) : 2098-2104.
Tan E.M. .1982 .The 1982 Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis & Rheumatism, 25(11) : 1271-1277.
Arnett F.C. . .The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis & Rheumatism, 31(1988) : 315-324.
Barnett A.J. . .A Survival Study of Patients with Scleroderma Diagnosed over 30 Years (1953-1983): The Value of a Simple Cutaneous Classification in the Early Stages of the Disease. ” Journal of Rheumatology, 15(1988) : 276-283.
Alam F. .2019 .Characteristics of Patients with Systemic Sclerosis Living in Qatar. Qatar Medical Journal, (2019) : 16.
Sujau I. .2015 .Clinical and Autoantibody Profile in Systemic Sclerosis: Baseline Characteristics from a West Malaysian Cohort. International Journal of Rheumatic Diseases, 18(4) : 459-465.
Simeón-Aznar C.P. . .Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status.” Seminars in Arthritis and Rheumatism. , 41(6) : 789-800.
Wielosz E. . .Comparison of Clinical and Serological Parameters in Female and Male Patients with Systemic Sclerosis. ” Reumatologia, 53(2015) : 315-320.
Hashimoto A.,April 2012 . .. Clinical Features of 405 Japanese Patients with Systemic Sclerosis.” Modern Rheumatology, 22(2) : 272-279.
Sujau I. .2015 .Clinical and Autoantibody Profile in Systemic Sclerosis: Baseline Characteristics from a West Malaysian Cohort. International Journal of Rheumatic Diseases, 18(4) : 459-465.
Al-Sheikh H. .2019 .Ethnic Variations in Systemic Sclerosis Disease Manifestations, Internal Organ Involvement and Mortality. ” Journal of Rheumatology, March, : .